For the Record - May 5, 2018

Opioid suit: In the May 4 California section, an article about Los Angeles suing nine opioid makers and distributors said that a Mallinckrodt spokeswoman said that Los Angeles officials had wrongfully targeted the company. The spokeswoman said that the company is “deeply committed to regulatory compliance and maintains industry-leading controls around the sale of its opioid products.”

If you believe that we have made an error, or you have questions about The Times’ journalistic standards and practices, you may contact Deirdre Edgar, readers’ representative, by email at readers.representative@latimes.com, by phone at (877) 554-4000, by fax at (213) 237-3535 or by mail at 202 W. 1st St., Los Angeles, CA 90012. The readers’ representative office is online at latimes.com/readersrep.